figshare
Browse
12885_2017_3100_MOESM2_ESM.docx (79.77 kB)

Additional file 2: Table S2. of The prognostic utility of the transcription factor SRF in docetaxel-resistant prostate cancer: in-vitro discovery and in-vivo validation

Download (79.77 kB)
journal contribution
posted on 2017-03-01, 05:00 authored by D. Lundon, A. Boland, M. Prencipe, G. Hurley, A O’Neill, E. Kay, S. Aherne, P. Doolan, S. Madden, M. Clynes, C. Morrissey, J. Fitzpatrick, R. Watson
Genes predicted to by dysregulated in the studied PC3 model of Docetaxel Resistance. AG = aged matched control, D8 = docetaxel resistant subline, D12 = docetaxel resistant subline. FC = fold change. (DOCX 79 kb)

Funding

Science Foundation Ireland, Molecular Therapeutics for Cancer in Ireland

History